1452-8258 < 1460-2091 < 1460-2385

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by 1460-2091

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000134 (2021)	Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran]	Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
000156 (2021)	Etienne Meriglier [France] ; Claire Rivoisy [France] ; Mojgan Hessamfar [France] ; Noelle Bernard [France] ; Ines Aureau [France] ; Joelle Lapoirie [France] ; Anne Contis [France] ; Frédéric Sacher [France] ; Benjamin Sacristan [France] ; Marin Lahouati [France] ; Stéphane Pedeboscq [France] ; Marie-Anne Vandenhende [France] ; Stéphane Bouchet [France] ; Fabrice Bonnet [France]	Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
000226 (2021)	Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Neant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]	Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response.
000420 (2021)	Boris Revollo [Espagne] ; Cristian Tebe [Espagne] ; Judith Pe Afiel [Espagne] ; Ignacio Blanco [Espagne] ; Nuria Perez-Alvarez [Espagne] ; Ruth Lopez [Espagne] ; Laura Rodriguez [Espagne] ; Josep Ferrer [Espagne] ; Pilar Ricart [Espagne] ; Enrique Moret [Espagne] ; Cristina Tural [Espagne] ; Anna Carreres [Espagne] ; Joan Matllo [Espagne] ; Sebastià Videla [Espagne] ; Bonaventura Clotet [Espagne] ; Josep M. Llibre [Espagne]	Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
000519 (2021)	Zakariya Kashour [Canada] ; Muhammad Riaz [Pakistan] ; Musa A. Garbati [Nigeria] ; Oweida Aldosary [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite] ; Dana Gerberi [États-Unis] ; M Hassan Murad [États-Unis] ; M Rizwan Sohail [États-Unis] ; Tarek Kashour [Arabie saoudite] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis]	Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
000602 (2021)	Bruno Mégarbane [France] ; Jean-Michel Scherrmann [France]	Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
000704 (2021)	James H. Mcmahon [Australie] ; Michael J. Lydeamore [Australie] ; Andrew J. Stewardson [Australie]	Bringing evidence from press release to the clinic in the era of COVID-19.
000B09 (2020)	Gholamali Eslami [Iran] ; Sajedeh Mousaviasl [Iran] ; Esmat Radmanesh [Iran] ; Saeed Jelvay [Iran] ; Saeid Bitaraf [Iran] ; Bryony Simmons [Royaume-Uni] ; Hannah Wentzel [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Anahita Sadeghi [Iran] ; James Freeman [Nouvelle-Zélande] ; Shokrollah Salmanzadeh [Iran] ; Hani Esmaeilian [Iran] ; Morteza Mobarak [Iran] ; Ramin Tabibi [Iran] ; Amir Hosein Jafari Kashi [Iran] ; Zahra Lotfi [Iran] ; Seyed Mehdi Talebzadeh [Iran] ; Aseni Wickramatillake [Sri Lanka] ; Mahboobeh Momtazan [Iran] ; Majid Hajizadeh Farsani [Iran] ; Sedigheh Marjani [Iran] ; Sara Mobarak [Iran]	The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
000D67 (2020)	Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Néant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France]	Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
001297 (2020)	Juliette Kauv [France] ; Minh P. Lê [France] ; Marc Veyrier [France] ; Quentin Le Hingrat [France] ; Benoit Visseaux [France] ; Laurent Massias [France] ; Marie-Paule Chauveheid [France] ; Diane Descamps [France] ; Jade Ghosn [France] ; Gilles Peytavin [France]	Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
001399 (2020)	Catherine Hodge [Royaume-Uni] ; Fiona Marra [Royaume-Uni] ; Catia Marzolini [Royaume-Uni, Suisse] ; Alison Boyle [Royaume-Uni] ; Sara Gibbons [Royaume-Uni] ; Marco Siccardi [Royaume-Uni] ; David Burger [Pays-Bas] ; David Back [Royaume-Uni] ; Saye Khoo [Royaume-Uni]	Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
001539 (2020)	Kwong-Lam Fung [Hong Kong] ; Ping-Lung Chan [Hong Kong]	Comment on: COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
001707 (2020)	Dan Zhou [République populaire de Chine] ; Sheng-Ming Dai [République populaire de Chine] ; Qiang Tong [République populaire de Chine]	COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
001759 (2020)	M. Lahouati [France] ; E. Mériglier [France] ; L. Martin [France] ; S. Bouchet [France] ; A. Desclaux [France] ; F. Bonnet [France]	COVID-19 infection also occurs in patients taking hydroxychloroquine.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1460-2091" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1460-2091" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1460-2091
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021